Cadila Healthcare informs about press release

02 Jun 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Doxycycline Hyclate Capsules USP’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

892.70 10.75 (1.22%)
27-Jan-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.70
Dr. Reddys Lab 1244.30
Cipla 1307.25
Zydus Lifesciences 892.70
Lupin 2150.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×